Arcutis Biotherapeutics, Inc. SEC filings ARQT
Arcutis Biotherapeutics, Inc. has 866 filings in SEC EDGAR's recent list, going back to Sep 9, 2019. Its latest annual report, Form ARS, was filed on Apr 21, 2026 for the period ended Apr 21, 2026. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| UPLOAD | Letter from the SEC | Dec 2, 2025 | — |
| CORRESP | Letter to the SEC | Oct 10, 2025 | — |
| UPLOAD | Letter from the SEC | Sep 15, 2025 | — |
| SC TO-I/A | Filing | Feb 15, 2024 | — |
| EFFECT | Filing | Feb 8, 2024 | — |
| CORRESP | Letter to the SEC | Feb 6, 2024 | — |
| UPLOAD | Letter from the SEC | Feb 5, 2024 | — |
| CORRESP | Letter to the SEC | Jan 24, 2024 | — |
| SC TO-I/A | Filing | Jan 24, 2024 | — |
| UPLOAD | Letter from the SEC | Jan 23, 2024 | — |
| SC TO-I | Filing | Jan 16, 2024 | — |
| SC TO-C | Filing | Jan 11, 2024 | — |
| UPLOAD | Letter from the SEC | Sep 18, 2023 | — |
| CORRESP | Letter to the SEC | Sep 15, 2023 | — |
| UPLOAD | Letter from the SEC | Sep 8, 2023 | — |
| UPLOAD | Letter from the SEC | May 4, 2021 | — |
| CORRESP | Letter to the SEC | Apr 23, 2021 | — |
| UPLOAD | Letter from the SEC | Apr 13, 2021 | — |
| EFFECT | Filing | Oct 1, 2020 | — |
| CORRESP | Letter to the SEC | Sep 29, 2020 | — |
| CORRESP | Letter to the SEC | Sep 29, 2020 | — |
| UPLOAD | Letter from the SEC | Jul 27, 2020 | — |
| DRS | Filing | Jul 21, 2020 | — |
| EFFECT | Filing | Jan 30, 2020 | — |
| SEC STAFF LETTER | Filing | Jan 29, 2020 | — |
| CERT | Filing | Jan 29, 2020 | — |
| CORRESP | Letter to the SEC | Jan 28, 2020 | — |
| CORRESP | Letter to the SEC | Jan 28, 2020 | — |
| SEC STAFF LETTER | Filing | Jan 27, 2020 | — |
| 8-A12B | Filing | Jan 21, 2020 | — |
| CORRESP | Letter to the SEC | Jan 13, 2020 | — |
| DRS/A | Filing | Dec 13, 2019 | — |
| DRSLTR | Filing | Nov 12, 2019 | — |
| DRS/A | Filing | Nov 12, 2019 | — |
| UPLOAD | Letter from the SEC | Oct 31, 2019 | — |
| D | Filing | Oct 22, 2019 | — |
| DRS/A | Filing | Oct 21, 2019 | — |
| DRSLTR | Filing | Oct 18, 2019 | — |
| UPLOAD | Letter from the SEC | Oct 7, 2019 | — |
| DRS | Filing | Sep 9, 2019 | — |
Showing 40 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ARQT (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Westlake Village, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1787306
- Former names
- Arcutis, Inc. (until Sep 9, 2019)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.